Study of Natural Course Progression of Diabetic Retinopathy

Recruiting Observational Study
Biomarkers of Diabetic Retinopathy
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 75
Sex
Any
Study type
Observational
Participants needed
200 (estimated)
Sponsor
Jie Li · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this observational study is to observe the formation and development of the non-perfusion area of diabetic retinopathy in the posterior area of the retina in type 2 diabetes patients aged 18-75 years old, who can cooperate with all examinations and sign informed consent, clinical myopathy examination and Optos 7 field of vision with mild than severe NPDR, and no other exclusion indicat…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion criteria: * Patients with type 2 diabetes aged 18-75 years * Can cooperate with the inspection and sign the informed consent * There are no other eye diseases that cause retinal neovascularization * There is no known substantial media haze that would hinder fundus image acquisition * No h…
Contacts

Jie Li, doctor

+86 13908094675

lijieyk@med.uestc.edu.cn

CONTACT